Results 161 to 170 of about 5,696 (212)

Caproate Production From Xylose by Mesophilic Mixed Culture Fermentation

Bioresource Technology, 2020
Caproate production by mixed culture fermentation (MCF) is economically attractive. Xylose is known as the second most abundant sugar in nature, however, producing caproate from xylose is never reported.
Fang Zhang, Raymond Jianxiong Zeng, Zi-Qian Geng   +2 more
exaly   +2 more sources

Effect of n-Caproate Concentration on Chain Elongation and Competing Processes

ACS Sustainable Chemistry and Engineering, 2018
Chain elongation is an open-culture fermentation process that facilitates conversion of organic residues with an additional electron donor, such as ethanol, into valuable n-caproate.
Ruud A Weusthuis, Mark Roghair, Cees J N Buisman   +2 more
exaly   +3 more sources

Caproate Formation in Mixed-Culture Fermentative Hydrogen Production

Bioresource Technology, 2010
Caproate always appears during fermentative H2 production but its formation was not well explained. It possibly results from the secondary fermentation of ethanol and acetate or butyrate by some special species like Clostridium kluyveri.
Giin-Yu Amy Tan, Jing-Yuan Wang
exaly   +2 more sources

Biological Caproate Production by Clostridium kluyveri From Ethanol and Acetate as Carbon Sources [PDF]

Bioresource Technology, 2017
Caproate is a valuable industrial product and chemical precursor. In this study, batch tests were conducted to investigate the fermentative caproate production through chain elongation from acetate and ethanol.
Yanan Yin, Shizong Wang, Yifeng Zhang
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Influence of gestonorone caproate on rat prostate

Journal of Steroid Biochemistry, 1979
Abstract The mechanism of action of weight reduction of the ventral prostate by gestonorone caproate (GC) in rats was studied. GC was subcutaneously injected (100 mg/week/rat) for 3 weeks in normal rats, castrated rats, castrated rats treated with testosterone propionate (TP, 0.03–0.24 mg/2 days/rat) and hypophysectomized rats treated with human ...
T, Hayashi, H J, Glotz, T, Aono, K, Matsumoto   +3 more
openaire   +2 more sources

Accelerated Approval of 17α-Hydroxyprogesterone Caproate

Obstetrics & Gynecology, 2020
Before 2011, 17α-hydroxyprogesterone caproate (17P) was used to prevent recurrent preterm birth in women with singleton pregnancies and was compounded at a low cost (∼$15 per injection). In 2011, the U.S. Food and Drug Administration (FDA) approved a commercial version of 17P (trade name “Makena”) through their Accelerated Approval Program, and the ...
Bethany J, Godlewski, Lily I, Sobolik, Valerie J, King, Curtis S, Harrod   +3 more
openaire   +2 more sources

Dihydroxybergamottin Caproate as a Potent and Stable CYP3A4 Inhibitor

Bioorganic & Medicinal Chemistry, 2002
We investigated the inhibitory activity of the furanocoumarin derivatives from grapefruit juice to the drug metabolizing enzyme, cytochrome P450 (CYP) 3A4. Although two known furanocoumarin dimers GF-I-1 (1) and GF-I-4 (2) showed potent CYP3A4 inhibition with IC50 value of 0.07 microM, a semi-synthetic dihydroxybergamottin caproate (11), which was more
Tomihisa, Ohta, Minoru, Nagahashi, Shinzo, Hosoi, Sachiko, Tsukamoto   +3 more
openaire   +2 more sources

Prevention of premature labor by 17α-hydroxyprogesterone caproate

American Journal of Obstetrics and Gynecology, 1985
Eighty pregnant women at high risk of giving birth prematurely were divided randomly into two groups. Treatment with either 17 alpha-hydroxyprogesterone caproate, 250 mg by intramuscular injection once a week, or a placebo was given in a double-blind fashion.
M, Yemini, R, Borenstein, E, Dreazen, Z, Apelman, B M, Mogilner, I, Kessler, M, Lancet   +6 more
openaire   +2 more sources

Association of 17α-Hydroxyprogesterone Caproate and Risk of Infection

Obstetrics & Gynecology, 2015
To evaluate whether exposure to 17α-hydroxyprogesterone caproate is associated with the rate of peripartum infection in women who deliver preterm and their neonates.This is a retrospective cohort study of patients who delivered before 37 weeks of gestation at a tertiary care hospital between July 1, 2005, and December 31, 2012. Women in the case group (
Alexandra D, Mainiero, Dwight J, Rouse, Vrishali, Lopes, Brenna L, Hughes   +3 more
openaire   +2 more sources

Stability of hydroxyprogesterone caproate alone and in a compounded pharmaceutical product

American Journal of Health-System Pharmacy, 2014
The chemical stability of hydroxyprogesterone caproate in powder form and in a pharmaceutical formulation under different experimental conditions was evaluated.Pure hydroxyprogesterone caproate was subjected to hydrolysis, photolysis, and thermal degradation.
Yang, Zhao, Joseph, Bettinger, Steve, Caritis, Raman, Venkataramanan   +3 more
openaire   +2 more sources